Stock Analysis
Envista Holdings Corp (NVST) Stock Analysis
Envista Holdings Corp (NVST) stock analysis covering valuation, fundamentals, technical indicators, risk, AIQ Momentum, analyst catalysts, dividends, and the current AIQ Score.
Envista Holdings Corp (NVST) currently has an AIQ Score of 52/100, indicating a neutral setup. Risk is the strongest factor at 69/100. Momentum is the weakest current factor at 33/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
NVST at a Glance
Crawlable current metrics from the latest market-close stock snapshot.
| Metric | Current |
|---|---|
| Price | $25.55 |
| AIQ Score | 52/100 |
| Overall View | Neutral |
| Technical Analysis Consensus | Strong Sell |
| Market Cap | $4.34B |
| P/E Ratio | 18.12 |
| Forward P/E | — |
| EPS | $0.33 |
| Revenue TTM | $730.5M |
| Dividend Yield | 0.00% |
| Beta | 0.86 |
| Volume | 3.99M |
| 52-week range | $18.77-$30.42 |
| RSI 14 | 32.7 |
| 50-Day SMA | $27.16 |
| 200-Day SMA | $25.44 |
| Analyst Price Target | $29.70 |
| Next Earnings | Nov 4, 2026 |
NVST
OverviewNVST Stock Analysis Summary
Envista Holdings Corp (NVST) currently has an AIQ Score of 52/100, indicating a neutral setup. Risk resilience is the strongest factor at 69/100. Momentum is the weakest current factor at 33/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
In a neutral regime, NVST has AIQ Score of 52/100 with Risk resilience base of 69/100 and fading Momentum at 33/100. Wait for component alignment before adding exposure.
Risk resilience (69/100) leads while Momentum (33/100) lags. This cross-factor spread creates entry timing uncertainty.
Healthcare · -1.24% stock move · NVST classified in Medical - Instruments & Supplies.
Current Evidence
AlgovestIQ Evidence Summary
Current consensus, supporting evidence, recent changes, and what would strengthen or weaken the view.
Is NVST Bullish or Bearish Right Now?
NVST currently has a neutral overall setup. Risk Resilience is the strongest factor at 69/100, while Momentum is weakest at 33/100. The current evidence suggests a mixed rather than strongly bullish or bearish setup.
- - Risk Resilience is supportive at 69/100.
- - Analyst target implies +16.24% upside from the latest quote.
- - Momentum is weak at 33/100.
- - Technical consensus has more sell votes than buy votes (35 vs 7).
Current Consensus
NVST's Technical Analysis Consensus is currently Strong Sell, with 7 buy, 3 neutral, and 35 sell votes. NVST's 14-day RSI is 32.7, which places the stock in a weaker momentum range. NVST's beta is 0.86, indicating market sensitivity broadly in line with the market.
What Changed in NVST?
Recent score-change history is not available in the current snapshot. These are the latest market-close scores instead.
What Would Change the NVST Outlook?
The current neutral outlook could improve if AIQ moves above 70, momentum recovers, earnings revisions strengthen, and price confirms a stronger trend above the 50-day and 200-day moving averages. It would weaken if AIQ falls below 40, price loses long-term moving-average support, analyst expectations deteriorate, or risk evidence worsens.
AIQ > 70, RSI above 55, price above SMA-50/SMA-200, and positive catalyst or estimate-revision evidence.
AIQ below 40, RSI below 45, loss of SMA-200, negative revisions, or rising volatility and drawdown risk.
NVST Decision Framework
Public evidence layers, setup checks, and risk context for Envista Holdings Corp.
Envista Holdings Corp (NVST) Stock Analysis
Envista Holdings Corp has an AIQ Score of 52/100 in a Neutral regime. Risk is strongest at 69/100. Beta is 0.86, below market sensitivity. Review the supporting stock factors together before drawing a conclusion from any single score.
| Evidence Layer | Public Evidence |
|---|---|
| Regime Context | NVST is in a Neutral AIQ regime with score 52/100. |
| Signal Conflict | The primary conflict is that risk leads at 69/100 while momentum lags at 33/100. |
| Factor Evidence | Momentum 33/100 · Value 62/100 · Quality 51/100 · Risk 69/100 |
| Persistence | Current snapshot evidence is shown; historical persistence remains in AIQ Pro. |
Current Setup Checklist
Risk is the strongest factor at 69/100.
Momentum is 33/100 and RSI (14) is 32.7.
NVST is in a Neutral regime at 52/100.
Risk factor is 69/100 with beta 0.86 and annual volatility 37.56%.
Current conflict: risk leads at 69/100 while momentum lags at 33/100.
NVST Research Cluster
Ticker-specific paths for valuation, technical analysis, catalysts, dividends, financials, risk, and news.
NVST Fundamentals
NVST valuation, profitability, growth, margins, balance-sheet strength, and free cash flow.
NVST Technical Analysis
NVST technical setup based on RSI, MACD, moving averages, AIQ Momentum, volume, trend, volatility, and pivots.
NVST Stock Catalysts
Track NVST earnings, analyst ratings, price targets, estimate revisions, stock news, and upcoming events.
NVST Dividend Analysis
NVST dividend yield, annual dividend, payout ratio, payment history, and income reliability context.
NVST Financial Data
NVST revenue, earnings, income statement, balance sheet, cash flow, valuation ratios, and stock metrics.
NVST Risk Analysis
NVST volatility, beta, drawdown, Sharpe ratio, VaR, and downside resilience.
NVST Stock News
NVST stock news, market tone, recent headlines, and catalyst context.
NVST vs Medical Devices Peers
Current peer cohort: NVST · OMCL · PODD · RMD · SOLV. Compare AIQ, factor scores, Sharpe ratio and 1-year volatility in one indexable view.
| Peer | AIQ | Value | Momentum | Risk | Sharpe | 1Y Volatility | Compare |
|---|---|---|---|---|---|---|---|
| NVST Current stock | 52/100 | 62/100 | 33/100 | 69/100 | 0.63 | 37.56% | Current |
| OMCL Omnicell | 50/100 | 62/100 | 29/100 | 59/100 | 0.23 | 50.99% | NVST vs OMCL |
| PODD Insulet | 51/100 | 46/100 | 22/100 | 59/100 | -1.97 | 44.63% | NVST vs PODD |
| RMD ResMed | 54/100 | 42/100 | 29/100 | 70/100 | -0.75 | 28.46% | NVST vs RMD |
| SOLV Solventum | 61/100 | 67/100 | 50/100 | 56/100 | 0.71 | 29.78% | NVST vs SOLV |
Peer cohort is resolved dynamically from the AlgovestIQ universe taxonomy and Compare relationship graph. Data as of Sep 11, 2026.
About the AIQ Score
Methodology for the current stock evidence.
The AlgovestIQ AIQ Score combines multiple dimensions of stock evidence, including momentum, valuation exposure, quality, risk resilience, sentiment context, and timing signals. It is a descriptive research score, not a guarantee of future performance or a personalized recommendation.
View AIQ methodologyFactor Diagnostics
A compact bridge from the AIQ score to the evidence tabs.
Open the return calculator with stock context while purchase price, shares, dates and fees remain user inputs.
AIQ Component Profile
Compare the five component scores on one consistent 0–100 scale.
Review earnings timing, revisions, news pressure, and prior event reactions in one place.
Open catalysts8 recent quarterly periods are available for review.
Checked Sep 12, 2026
Explore factor drivers, conflicts, persistence, and scenario sensitivity in the advanced workspace.
Fundamentals Verdict
Current snapshot fields are separate from reported-quarter statement tables.
Latest period Jul 3, 2026.
Market Confirmation
Technicals are summarized first, with the indicator library behind it.
Risk Alignment
Higher resilience is stronger; exposure metrics stay separate.
Continue Researching NVST
Open the detailed evidence pages and workflows behind the stock overview read.
Premium Feature
Full AIQ Analysis
AIQ Intelligence
AIQ Pro for NVST
Scenario Analysis
AIQ Scenario Builder
Portfolio Implication
Related Links
NVST Stock FAQ
What is NVST stock price today?
Envista Holdings Corp's current stock price is $25.55. Use the live quote with AIQ Score, news, and risk context rather than treating price alone as a decision signal.
Is NVST bullish or bearish right now?
NVST's bullish or bearish read depends on the current AIQ Score, factor alignment, technical analysis consensus, valuation, risk, and catalyst evidence. A mixed setup should be treated differently from a broad confirmation across those signals.
What is NVST's market cap?
NVST's market cap is $4.34B based on the latest completed market-close snapshot from Sep 11, 2026. Use it with P/E ratio, revenue, and growth metrics to frame company size, valuation, and peer comparisons.
What is NVST's current P/E ratio?
NVST's current P/E ratio is 18.12 based on the latest completed market-close snapshot from Sep 11, 2026. Read it with revenue growth, margins, EPS, cash flow, and peer valuation rather than using P/E alone.
What is NVST's RSI?
NVST's 14-day RSI is 32.7 based on the latest completed market-close snapshot from Sep 11, 2026. RSI should be interpreted with MACD, moving averages, volume, volatility, and price trend.
Is NVST above its 50-day and 200-day moving averages?
NVST is -5.93% from its 50-day SMA and 0.45% from its 200-day SMA based on the latest completed market-close snapshot from Sep 11, 2026. Moving-average position should be read with momentum and broader AIQ evidence.
When is NVST's next earnings date?
NVST's next earnings date is currently listed as Nov 4, 2026. Earnings can reset revenue, EPS, price target, analyst rating, and catalyst expectations.
Does NVST pay a dividend?
NVST's dividend yield is 0.00% based on the latest completed market-close snapshot from Sep 11, 2026. Dividend yield should be read with payout ratio, free cash flow, growth, and balance-sheet strength.